Nephrol Dial Transplant (1999) 14: 2288-2290
© 1999 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Haemodialysis catheter-related infection: time for action
Nephrology, Lapeyronie University Hospital, Montpellier, France
Correspondence and offprint requests to: Prof. Bernard Canaud, Nephrology, Lapeyronie University Hospital, 395, Av du Doyen G Giraud, F-34295 Montpellier, France. e-mail: Bcanaud@aol.com
Introduction
Central venous catheters were a major advance in end-stage renal disease (ESRD) patient care until the burden of catheter-related complications became obvious. Catheter-related infection is one of the major causes of morbidity, with potential lethal hazards in haemodialysis patients. Today, the incidence of bacteraemia ranges from 0.5 to 13 per 1000 patient-days with haemodialysis catheters. Lower rates are observed with permanent silicone catheters (cuffed or non-cuffed) and higher ones with temporary polyurethane catheters. In a recent multicentre prospective study involving 988 ESRD patients it has been estimated that the relative risk of bacteraemia was 7.64-fold higher in patients requiring catheters (n=58; 5.9%) as compared to those having a native arteriovenous fistula [1]. In order to reduce infections related to the use of haemodialysis catheter, it is time to address the following issues: first, evaluating the burden; second, defining infection-related catheters; third, identifying risk factors; fourth, making recommendations and
Epidemiological facts
Time for definitions
Time for identifying risk factors
Time for new technical solutions and recommendations
Conclusion
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Eloot, J.-Y. De Vos, and R. Hombrouckx How much is red blood cell fragmentation increased by the use of closed luer lock access devices on catheter hubs? NDT Plus, December 1, 2008; 1(6): 409 - 411. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Eloot, J.-Y. De Vos, R. Hombrouckx, and P. Verdonck How much is catheter flow influenced by the use of closed luer lock access devices? Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3061 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ortega, F. Ortega, C. Diaz-Corte, P. Rebollo, J. Ma Baltar, and J. Alvarez-Grande The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management Nephrol. Dial. Transplant., March 1, 2005; 20(3): 598 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cappelli, C. Tetta, and B. Canaud Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis Nephrol. Dial. Transplant., February 1, 2005; 20(2): 266 - 270. [Full Text] [PDF]
|
|
|
|
|
|
V. Mickley Surgical alternatives to central venous catheters in chronic renal replacement therapy Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1045 - 1051. [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Dogra, H. Herson, B. Hutchison, A. B. Irish, C. H. Heath, C. Golledge, G. Luxton, and H. Moody Prevention of Tunneled Hemodialysis Catheter-Related Infections Using Catheter-Restricted Filling with Gentamicin and Citrate: A Randomized Controlled Study J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2133 - 2139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Coronel, J. A. Herrero, P. Mateos, M. L. Illescas, J. Torrente, and M. J. d. Valle Long-term experience with the Thomas shunt, the forgotten permanent vascular access for haemodialysis Nephrol. Dial. Transplant., September 1, 2001; 16(9): 1845 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lemus, H. Parra, and A. Undurraga Antibiotic management of infected vascular access Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1521 - 1521. [Full Text] [PDF]
|
|